stockrowTransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) Revenue growth
TransMedics Group, Inc.'s revenue growth over the twelve months to 30 September 2026 was 28.5%, down 8.6 percentage points from fiscal 2025 (37.1%). Over the past ten years it has ranged from −19.2% (fiscal 2016) to 208.8% (fiscal 2022); the current reading is higher than 50% of that period. That is above the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 37.1% | (45.61) |
| FY2024 | 82.7% | (75.79) |
| FY2023 | 158.5% | (50.30) |
| FY2022 | 208.8% | 190.80 |
| FY2021 | 18.0% | 9.41 |
| FY2020 | 8.62% | (72.71) |
| FY2019 | 81.3% | 11.95 |
| FY2018 | 69.4% | 45.61 |
| FY2017 | 23.8% | 42.98 |
| FY2016 | −19.2% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 41.2% | 20.45 |
| Jun 2026 | 20.7% | (0.48) |
| Mar 2026 | 21.2% | (11.00) |
| Dec 2025 | 32.2% | (0.06) |
| 31 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BFLY Butterfly Network, Inc. compare | 39.4% |
| ESTA Establishment Labs Holdings Inc. compare | 38.6% |
| TMDX TransMedics Group, Inc. | 28.5% |
| AXGN AxoGen, Inc. compare | 24.3% |
| NVCR NovoCure Limited compare | 12.9% |
| UFPT UFP Technologies, Inc. compare | 8.62% |
| INSP Inspire Medical Systems, Inc. compare | −0.19% |
| NEOG Neogen Corporation compare | −0.33% |
| ALMR Alamar Biosciences, Inc. compare | — |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement